Nations Financial Group Inc. IA ADV Sells 114 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Nations Financial Group Inc. IA ADV reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,829 shares of the financial services provider’s stock after selling 114 shares during the period. Nations Financial Group Inc. IA ADV’s holdings in iShares Biotechnology ETF were worth $412,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Peregrine Asset Advisers Inc. increased its holdings in iShares Biotechnology ETF by 6.8% in the 3rd quarter. Peregrine Asset Advisers Inc. now owns 3,467 shares of the financial services provider’s stock valued at $505,000 after acquiring an additional 222 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $36,000. Tyler Stone Wealth Management grew its stake in shares of iShares Biotechnology ETF by 128.0% in the 3rd quarter. Tyler Stone Wealth Management now owns 5,747 shares of the financial services provider’s stock worth $837,000 after buying an additional 3,226 shares in the last quarter. Sigma Planning Corp grew its stake in shares of iShares Biotechnology ETF by 11.7% in the 3rd quarter. Sigma Planning Corp now owns 7,083 shares of the financial services provider’s stock worth $1,031,000 after buying an additional 743 shares in the last quarter. Finally, Objective Capital Management LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $445,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $140.09 on Friday. iShares Biotechnology ETF has a 52 week low of $116.70 and a 52 week high of $150.57. The firm has a fifty day simple moving average of $144.68 and a two-hundred day simple moving average of $141.56.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.